Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Cardiologists make history | A surprising way COVID-19 affects the heart | AHA & CRF join forces
Friday, August 19, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologists make history, becoming first to use FDA-cleared retrieval device to remove a heart tumor

The historic procedure took approximately 30 minutes, and the patient went home that same day. 

READ MORE >
Interventional cardiologists at the University of Washington (UW) have used the new Ōnocor catheter-delivered retrieval device to remove a benign tumor from a patient’s heart. This is the first time such a device has ever been used to remove a heart tumor.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists make history, becoming first to use FDA-cleared retrieval device to remove a heart tumor

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologists at the University of Washington (UW) have used the new Ōnocor catheter-delivered retrieval device to remove a benign tumor from a patient’s heart. This is the first time such a device has ever been used to remove a heart tumor.
The historic procedure took approximately 30 minutes, and the patient went home that same day. 
READ MORE >

PET imaging uncovers a surprising new way COVID-19 affects the heart

A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward. 

READ MORE >
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
Share on Twitter Share on Facebook Share on Linkedin

PET imaging uncovers a surprising new way COVID-19 affects the heart

Share on Twitter Share on Facebook Share on Linkedin
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward. 
READ MORE >

American Heart Association and Cardiovascular Research Foundation announce a new annual meeting collaboration

“Harnessing the strengths of our two pioneering organizations with extensive experience in translating the latest scientific breakthroughs into practical therapies is crucial," says AHA CEO Nancy Brown.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association and Cardiovascular Research Foundation announce a new annual meeting collaboration

Share on Twitter Share on Facebook Share on Linkedin
“Harnessing the strengths of our two pioneering organizations with extensive experience in translating the latest scientific breakthroughs into practical therapies is crucial," says AHA CEO Nancy Brown.
READ MORE >

Featured Articles

TAVR programs follow inconsistent DNR policies, potentially skewing data

Not all hospitals respect the written preferences of patients, possibly motivated by a desire to report better TAVR outcomes.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TAVR programs follow inconsistent DNR policies, potentially skewing data

Share on Twitter Share on Facebook Share on Linkedin
Not all hospitals respect the written preferences of patients, possibly motivated by a desire to report better TAVR outcomes.
READ MORE >

American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification

The new certification, based on recommendations published in Circulation, was developed to signal that a facility offers cardiac surgery and primary PCI at all times. 

READ MORE >
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification

Share on Twitter Share on Facebook Share on Linkedin
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
The new certification, based on recommendations published in Circulation, was developed to signal that a facility offers cardiac surgery and primary PCI at all times. 
READ MORE >

In Case You Missed It

TCT 2022 late-breaking clinical presentations announced

The Cardiovascular Research Foundation (CRF) announced the 32 late-breaking studies being presented at the Transcatheter Cardiovascular Therapeutics 2022 annual meeting at in Boston, Sept. 16-19.

READ MORE >
A structural heart Presentation during the TVT 2022 conference. #TCT #TCT22 #TCT2022
Share on Twitter Share on Facebook Share on Linkedin

TCT 2022 late-breaking clinical presentations announced

Share on Twitter Share on Facebook Share on Linkedin
A structural heart Presentation during the TVT 2022 conference. #TCT #TCT22 #TCT2022
The Cardiovascular Research Foundation (CRF) announced the 32 late-breaking studies being presented at the Transcatheter Cardiovascular Therapeutics 2022 annual meeting at in Boston, Sept. 16-19.
READ MORE >

In Other News

14% of physicians say they've had alcohol or drugs on the job

More physicians are turning to alcohol and substances to deal with unprecedented levels of stress, trauma and burnout at work––and some are even drinking on the job.

READ MORE >
women burnout
Share on Twitter Share on Facebook Share on Linkedin

14% of physicians say they've had alcohol or drugs on the job

Share on Twitter Share on Facebook Share on Linkedin
women burnout
More physicians are turning to alcohol and substances to deal with unprecedented levels of stress, trauma and burnout at work––and some are even drinking on the job.
READ MORE >

CVS, Walgreens and Walmart ordered to pay $650M for role in opioid epidemic

Three major pharmacy names will have to fork over hundreds of millions of dollars to two Ohio counties for their roles in the opioid epidemic, a judge has ruled.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

CVS, Walgreens and Walmart ordered to pay $650M for role in opioid epidemic

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Three major pharmacy names will have to fork over hundreds of millions of dollars to two Ohio counties for their roles in the opioid epidemic, a judge has ruled.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme